Publikationen von Florian Holsboer

Ising, M.; Horstmann, S.; Kloiber, S.; Lucae, S.; Binder, E. B.; Kern, N.; Künzel, H.; Pfennig, A.; Uhr, M.; Holsboer, F.: Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major-depression-A potential biomarker? Biological Psychiatry 62 (1), S. 47 - 54 (2007)

Kaufmann, C.; Wehrle, R.; Wetter, T. C.; Holsboer, F.; Auer, D. P.; Pollmächer, T.; Czisch, M.: Beyond noise: reply to Laufs et al. Brain 130 (7), doi:10.1093/brain/awm085, S. e76 - e76 (2007)

Marsch, R.; Foeller, E.; Rammes, G.; Bunck, M.; Kössl, M.; Holsboer, F.; Zieglgänsberger, W.; Landgraf, R.; Lutz, B.; Wotjak, C. T.: Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. The Journal of Neuroscience 27 (4), S. 832 - 839 (2007)

Modell, S.; Ising, M.; Holsboer, F.; Lauer, C. J.: Regarding "The Munich Vulnerability-Study on Affective Disorders: Premorbid Polysomnographic Profile of Affected High-Risk Probands" Reply. Biological Psychiatry 62, S. 702 - 704 (2007)

Reppermund, S.; Zihl, J.; Lucae, S.; Horstmann, S.; Kloiber, S.; Holsboer, F.; Ising, M.: Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation. Biological Psychiatry 62 (5), S. 400 - 406 (2007)

Thoeringer, C. K.; Binder, E. B.; Salyakina, D.; Erhardt, A.; Ising, M.; Unschuld, P. G.; Kern, N.; Lucae, S.; Brueckl, T. M.; Mueller, M. B. et al.; Fuchs, B.; Puetz, B.; Lieb, R.; Uhr, M.; Holsboer, F.; Mueller-Myhsok, B.; Keck, M.: Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. Journal of Psychiatric Research 41, doi:10.1016/j.jpsychires.2006.06.001, S. 579 - 584 (2007)

Welt, T.; Engelmann, M.; Renner, U.; Erhardt, A.; Müller, M. B.; Landgraf, R.; Holsboer, F.; Keck, M. E.: Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: Novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress. Neuropsychopharmacology 31 (12), S. 2573 - 2579 (2006)

Prokopenko, I.; Tozzi, F.; Vicentini, E.; Vanzo, A.; Brewster, S.; Perry, J.; Chissoe, S.; Jean, P. S.; Bansal, A.; Upmanyu, R. et al.; Budde, L.; Allan, C.; Riley, J.; Domenici, E.; Merlo-Pich, E.; McCarthy, A.; Holsboer, F.; Roses, A.; Middleton, L.; Berrettini, W.; Kennedy, J.; Muglia, P.: Major depressive disorder: Genetic association analyses using subphenotypes. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 141B (7), S. 809 - 809 (2006)

Unschuld, P. G.; Erhardt, A.; Ising, M.; Lucae, S.; Kloiber, S.; Kohli, M.; Binder, E. B.; Müller-Myhsok, B.; Keck, M. E.; Holsboer, F.: An association candidate-gene study on genetic variations within HTR2A in patients suffering from panic disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 141B (7), S. 739 - 740 (2006)

Ditzen, C.; Jastorff, A. M.; Kessler, M. S.; Bunck, M.; Teplytska, L.; Erhardt, A.; Krömer, S. A.; Varadarajulu, J.; Targosz, B. S.; Sayan-Ayata, E. F. et al.; Holsboer, F.; Landgraf, R.; Turck, C. W.: Protein biomarkers in a mouse model of extremes in trait anxiety. Molecular & Cellular Proteomics 5 (10), S. 1914 - 1920 (2006)

Nguyen, N. K.; Keck, M. E.; Hetzenauer, A.; Thöringer, C. K.; Wurst, W.; Deussing, J. M.; Holsboer, F.; Müller, M. B.; Singewald, N.: Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge. Psychopharmacology 188 (3), S. 374 - 385 (2006)

Roedel, A.; Storch, C.; Holsboer, F.; Ohl, F.: Effects of light or dark phase testing on behavioural and cognitive performance in DBA mice. Laboratory Animals 40 (4), S. 371 - 381 (2006)

Castillo, V.; Giacomini, D.; Paez-Pereda, M.; Stalla, J.; Labeur, M.; Theodoropoulou, M.; Holsboer, F.; Grossman, A. B.; Stalla, G. K.; Arzt, E.: Retinoic acid as a novel medical therapy for Cushing's disease in dogs. Endocrinology 147 (9), S. 4438 - 4444 (2006)

Schüssler, P.; Yassouridis, A.; Uhr, M.; Kluge, M.; Weikel, J.; Holsboer, F.; Steiger, A.: Growth hormone-releasing hormone and corticotropin-releasing hormone enhance non-rapid-eye-movement sleep after sleep deprivation. American Journal of Physiology-Endocrinology and Metabolism 291 (3), S. E549 - E556 (2006)

Wehrle, R.; Sämann, P.; Harsay, H.; Wetter, T. C.; Holsboer, F.; Czisch, M.; Drummond, S. P.: Mapping effects of sleep deprivation with combined fMRI/EEG. Journal of Sleep Research 15 (Suppl. 1), S. 56 - 57 (2006)

Holsboer, F.: Detlev Ploog (1920 to 2005). Nervenarzt 77 (7), S. 852 - 853 (2006)

Müller, M. B.; Holsboer, F.: Mice with mutations in the HPA-system as models for symptoms of depression. Biological Psychiatry 59 (12), S. 1104 - 1115 (2006)

Barden, N.; Harvey, M.; Gagne, B.; Shink, E.; Tremblay, M.; Raymond, C.; Labbe, M.; Villeneuve, A.; Rochette, D.; Bordeleau, L. et al.; Stadler, H.; Holsboer, F.; Müller-Myhsok, B.: Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 141B (4), S. 374 - 382 (2006)

Then Bergh, F.; Kümpfel, T.; Schumann, E.; Held, U.; Schwan, M.; Blazevic, M.; Wismüller, A.; Holsboer, F.; Yassouridis, A.; Uhr, M. et al.; Weber, F.; Daumer, M.; Trenkwalder, C.; Auer, D. P.: Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurology 6 (19), doi:10.1186/1471-2377-6-19 (2006)

Steiner, M.; Marsicano, G.; Holsboer, F.; Lutz, B.; Wotjak, C. T.: Cannabinoid receptor 1 (CB1) signaling acts as a major regulatory mechanism of hypothalamus-pituitary-adrenal (HPA) axis mediated corticosterone secretion. Frontiers in Neuroendocrinology 27 (1), S. 39 - 39 (2006)